LAGI, FILIPPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.522
AS - Asia 3.414
EU - Europa 3.311
SA - Sud America 373
Continente sconosciuto - Info sul continente non disponibili 95
AF - Africa 90
OC - Oceania 42
Totale 11.847
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.403
RU - Federazione Russa 1.322
SG - Singapore 1.057
CN - Cina 1.048
IT - Italia 868
HK - Hong Kong 400
KR - Corea 315
BR - Brasile 284
PL - Polonia 254
VN - Vietnam 237
IE - Irlanda 161
DE - Germania 148
FR - Francia 130
SE - Svezia 121
FI - Finlandia 98
GB - Regno Unito 92
IN - India 79
BD - Bangladesh 72
CA - Canada 69
JO - Giordania 47
ID - Indonesia 43
AU - Australia 41
AR - Argentina 35
NL - Olanda 31
JP - Giappone 25
ES - Italia 21
MX - Messico 21
ZA - Sudafrica 19
NG - Nigeria 16
UA - Ucraina 16
EC - Ecuador 15
CH - Svizzera 14
PK - Pakistan 14
CO - Colombia 13
TR - Turchia 10
BJ - Benin 9
CL - Cile 9
IQ - Iraq 9
UZ - Uzbekistan 9
CI - Costa d'Avorio 8
PY - Paraguay 8
RO - Romania 8
EG - Egitto 7
PH - Filippine 7
VE - Venezuela 7
ET - Etiopia 6
JM - Giamaica 6
KE - Kenya 6
TN - Tunisia 6
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
EE - Estonia 4
LT - Lituania 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
OM - Oman 4
PR - Porto Rico 4
SA - Arabia Saudita 4
AT - Austria 3
AZ - Azerbaigian 3
DZ - Algeria 3
GT - Guatemala 3
LV - Lettonia 3
TW - Taiwan 3
AM - Armenia 2
CG - Congo 2
CR - Costa Rica 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
LU - Lussemburgo 2
NI - Nicaragua 2
PA - Panama 2
QA - Qatar 2
SY - Repubblica araba siriana 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GP - Guadalupe 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 11.749
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.070
Singapore 797
Ashburn 777
Hefei 376
Hong Kong 347
San Jose 344
Seoul 311
Warsaw 248
Dublin 161
Florence 138
Fairfield 126
Milan 125
Chandler 109
Council Bluffs 104
Dallas 101
Beijing 96
Los Angeles 94
Moscow 81
Munich 78
New York 72
The Dalles 66
Buffalo 65
Hanoi 65
Lauterbourg 63
Ho Chi Minh City 61
Rome 60
Helsinki 57
Kent 57
Altamura 51
Lawrence 50
Houston 44
Seattle 43
Phoenix 41
Melbourne 39
Woodbridge 39
Wilmington 38
Mumbai 35
Paris 35
Cambridge 34
Chicago 33
Jakarta 33
Princeton 31
London 30
São Paulo 26
Tokyo 24
Boston 22
Shanghai 21
Turku 21
Naples 20
Montreal 19
Bengaluru 17
Brooklyn 16
Frankfurt am Main 16
Guangzhou 16
Medford 16
Orem 16
Turin 16
Abuja 15
Lappeenranta 15
Denver 14
San Diego 14
Toronto 13
Ann Arbor 12
Poplar 12
West Jordan 12
Atlanta 11
Redondo Beach 11
Rio de Janeiro 11
Tianjin 11
Bari 10
Da Nang 10
Johannesburg 10
Madrid 10
Yubileyny 10
Bern 9
Cotonou 9
Nuremberg 9
Philadelphia 9
Washington 9
Abidjan 8
Bologna 8
Chennai 8
Dearborn 8
Miano 8
Tashkent 8
Boardman 7
Clifton 7
Elk Grove Village 7
Falkenstein 7
Haiphong 7
Hải Dương 7
Manchester 7
Mexico City 7
Shenzhen 7
Stockholm 7
Timisoara 7
Belo Horizonte 6
Charlotte 6
Dong Ket 6
Düsseldorf 6
Totale 7.286
Salva come PNG Salva come JPEG
Nome #
Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults 464
Imported dengue fever in Tuscany, Italy, in the period 2006 to 2012. 260
Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation? 224
Male reproductive system inflammation after healing from coronavirus disease 2019 217
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 213
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 203
Latent Tuberculosis Infection and COVID-19: Analysis of a Cohort of Patients from Careggi University Hospital (Florence, Italy) 201
Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study 200
Implementing Early Phase Treatments for COVID-19 in Outpatient Settings: Challenges at a Tertiary Care Center in Italy and Future Outlooks 200
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 197
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy 196
Early discharge criteria in patients with acute bacterial skin and skin structure infections in a large tertiary-care teaching hospital in Florence, Italy 195
Reply: COVID-19: Semen impairment may not be related to the virus 194
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 193
Arbo-score: A rapid score for early identification of patients with imported arbovirosis caused by Dengue, Chikungunya and zika virus 192
Treatment with anti-SARS-CoV-2 monoclonal antibodies in pregnant and postpartum women: first experiences in Florence, Italy 189
Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence, Italy 187
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 186
Facilitators and barriers in HIV testing and continuum of care among migrant transgender women who are sex workers residing in Florence, Italy 185
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience 184
Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 183
The prognostic role of IL-10 in non-severe COVID-19 with chemosensory dysfunction 181
Emergence of dengue fever: sentinel travellers uncover outbreak in Sharm El-Sheikh, Egypt, May 2024 178
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19 178
Can SSRI/SNRI antidepressants decrease the 'cytokine storm' in the course of COVID-19 pneumonia? 177
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies 173
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 173
Cancer population may be paradoxically protected from severe manifestations of COVID-19 172
Diagnostic accuracy of physician’s gestalt in suspected COVID-19: Prospective bicentric study 167
Babesiosis in the immunocompromised population: Results from a multicentric cohort study conducted in Italy 164
When it rains, it pours: Early treatment with tecovirimat of cardiac complications associated with monkeypox infection in a person with HIV and previously undiagnosed Lyme disease. A case report 164
Continuum of care among HIV-1 positive patients in a single center in Italy (2007–2017) 158
Tubercular prosthetic joint infection: two case reports and literature review 158
Comparison of the efficacy, safety and durability of a switch to co-formulated RPV/TDF-TAF/FTC or DTG/ABC/3TC in virologically-suppressed HIV-1-infected patients in a single Italian centre: a cohort data analysis 157
DYNAMIC OF TRANSMISSION AND ACQUISITION OF HIV AMONG MIGRANTS FROM PERU LIVING IN FLORENCE: IMPLICATIONS FOR EFFECTIVELY MANAGING HIV PREVENTION AND RETENTION PROGRAMMES 156
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study 155
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH) 154
Leptospirosis acquired by tourists in Venice, Italy 153
High-dose steroids for the treatment of severe COVID-19 152
Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study 152
The never-ending story of mpox epidemic: Tracing a new cluster in Florence, Italy 151
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort) 150
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 145
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 144
Procalcitonin for the differential diagnosis of COVID-19 in the emergency department. Prospective monocentric study 141
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 141
Efficacy and safety of Pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review 139
Prospective study on incidence, risk factors and outcome of recurrent clostridioides difficile infections 138
Use of colistin in adult patients: A cross-sectional study 137
Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 134
The burden of clostridioides difficile infection during the COVID-19 pandemic: A retrospective case-control study in Italian hospitals (CloVid) 133
UNAIDS 90-90-90 Target and Retention in Care of a Cohort of Migrants Living with HIV in a Tertiary Referral Hospital in Florence, Italy 133
Impact of rapid-antiretroviral therapy in a cohort of treatment-naïve migrants living with HIV in a high income setting 126
Imported dengue fever in Tuscany, Italy, in the period 2006 to 2012. 125
Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia 122
Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 121
Overall Tolerability of Integrase Inhibitors in Clinical Practice: Results from a Multicenter Italian Cohort 118
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study 118
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV 117
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 114
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients 113
Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriales infection: are they the same in neutropenic and non-neutropenic patients? 113
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort 110
Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort 110
Malattie Tropicali Neglette in un'area non endemica, la casistica del Centro di Riferimento della Regione Toscana per lo Studio e la Cura delle Malattie Tropicali (1999-2013) 110
Incidence of hypoglycaemia associated with transient loss of consciousness. A retrospective cohort study 107
Viro-immunological efficacy and tolerability of dolutegravir-based regimens compared to regimens based on other integrase strand inhibitors, protease inhibitors or non-nucleoside reverse transcriptase inhibitors in patients with acute HIV-1 infection: A multicenter retrospective cohort study 106
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 106
VIRO-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice 95
Transgender people living with HIV: characteristics and comparison to homosexual and heterosexual cisgender patients in two Italian teaching hospitals 94
Monkeypox: A novel pitfall in clinical dermatology 93
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study 92
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study 88
Serology-Based Screening and Prevalence of Schistosomiasis, Strongyloidiasis, and Chagas Disease in Migrants Living with HIV: Results from a 10-Year Retrospective Cohort in an Italian Tertiary Healthcare Center 67
Durability of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV) 62
Screening for Leishmania spp. infection in patients treated with biologic agents for immune-mediated inflammatory diseases: results of an Italian multicentric prospective study 37
Exploring mpox vaccination uptake and tolerability among people living with HIV: A study in an infectious disease unit in Italy 35
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry 32
Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry 28
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era 17
Totale 11.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.519
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022189 0 0 0 10 4 24 4 28 5 13 32 69
2022/2023723 45 151 44 20 26 120 100 43 88 13 53 20
2023/2024687 21 41 68 30 46 88 21 170 24 99 52 27
2024/20253.731 130 356 217 627 934 440 115 167 195 123 167 260
2025/20265.238 588 739 723 461 575 164 559 197 282 334 230 386
2026/2027606 153 102 324 27 0 0 0 0 0 0 0 0
Totale 11.847